Contractor
PINE PHARMACEUTICALS LLC
- UEI
- TCJXKNYD6WL5
- Parent UEI
- KLAVWTGSAWF6
- Resolved by
- uei
- Confidence
- 1.000
Active from Mar 5, 2026 to Jul 9, 2026.
Recent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 75N98026F00003 NIDDK: STABLE ISOTOPES DEUTERIUM OXIDE (D, 70%), GLYCEROL (D5 GLYCEROL), AND GLUCOSE (6,6 DEUTERATED GLUCOSE) | Department of Health and Human Services | NY | Jul 9, 2026 | $410,843 |
| 75N98026F00002 NIDDK METABOLIC ISOTOPES | Department of Health and Human Services | NY | Jun 11, 2026 | $54,487 |
| 36C26326N0200 503B COMPOUNDING PHARMACEUTICALS | Department of Veterans Affairs | NY | Mar 5, 2026 | $21,673 |
| 75N98026F00001 1. 26-003399 - IDIQ 75N94024D00003, SEND PO TO AGENTILE@PINEPHARMACEUTICALS.COM, DELIVERY BY 6/1/26; ORAL STABLE ISOTOPE-DEUTERIUM OXIDE, BILLING IN ONE LUMP SUM, NIH POC JEANNETTE.KIM@NIH.GOV | Department of Health and Human Services | NY | Apr 21, 2026 | $39,279 |
| 75N90020P00581 TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS. | Department of Health and Human Services | NY | Apr 14, 2026 | $0 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier TCJXKNYD6WL5, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Aug 10, 2026.